Active ingredient
Pyridostigmine
26 finished FDA listings contain Pyridostigmine as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- PYRIDOSTIGMINE BROMIDE
- Dosage forms
- Injection, Solution, Solution, Tablet, Tablet, Extended Release
- Routes
- Intravenous, Oral, Parenteral
- Manufacturers / labelers
- 21
- Strengths listed
- 105 mg/1 · 180 mg/1 · 30 mg/1 · 5 mg/ml · 60 mg/1 · 60 mg/5ml
- Brand names in FDA listings
- Mestinon, Pryidostigmine Bromide, Pyridostigmine, Regonol
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 9000
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 009829 | BAUSCH | 1955-04-06 | 1 |
| NDA 011665 | BAUSCH | 1959-01-12 | 2 |
| NDA 015193 | BAUSCH | 1965-01-25 | 1 |
| NDA 017398 | SANDOZ | 1973-08-14 | 1 |
| NDA 020414 | US ARMY | 2003-02-05 | 1 |
| ANDA 040502 | IMPAX LABS | 2003-04-24 | 3 |
| ANDA 040512 | ANI PHARMS | 2003-10-08 | 1 |
| ANDA 205650 | ZYDUS PHARMS | 2015-06-22 | 4 |
| ANDA 204737 | ALVOGEN | 2015-06-26 | 1 |
| ANDA 205464 | RISING | 2017-08-15 | 1 |
| ANDA 211181 | MLV | 2018-07-20 | 2 |
| ANDA 211694 | NOVITIUM PHARMA | 2019-03-08 | 2 |
| ANDA 208797 | RISING | 2020-01-09 | 2 |
| ANDA 212702 | AMNEAL | 2020-01-10 | 1 |
| ANDA 212405 | MILLA PHARMS | 2022-04-19 | 1 |
| ANDA 216512 | MSN | 2023-09-21 | 1 |
| NDA 217604 | AMNEAL | 2024-10-04 | 1 |
Official labeling on DailyMed
- REGONOL (PYRIDOSTIGMINE BROMIDE) INJECTION, SOLUTION [SANDOZ INC] · version 21 · 2026-08-20
- PYRIDOSTIGMINE BROMIDE TABLET [MAJOR PHARMACEUTICALS] · version 6 · 2026-08-20
- PYRIDOSTIGMINE BROMIDE SOLUTION [ACELLA PHARMACEUTICALS, LLC] · version 4 · 2026-07-13
- PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS LLC] · version 8 · 2026-05-15
- PYRIDOSTIGMINE BROMIDE TABLET [METHOD PHARMACEUTICALS, LLC] · version 2 · 2026-02-16
- PYRIDOSTIGMINE BROMIDE TABLET [SURGEON GENERAL-DEPARTMENT OF THE ARMY (TSG-DA)] · version 6 · 2026-01-30
- PYRIDOSTIGMINE BROMIDE SOLUTION [VISTAPHARM, LLC] · version 6 · 2025-11-26
- PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE [ALVOGEN, INC.] · version 14 · 2025-11-17
- PYRIDOSTIGMINE BROMIDE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] · version 17 · 2025-11-17
- PYRIDOSTIGMINE BROMIDE TABLET [METHOD PHARMACEUTICALS, LLC] · version 9 · 2025-11-17
- PYRIDOSTIGMINE BROMIDE TABLET [ANI PHARMACEUTICALS, INC.] · version 3 · 2025-08-07
- PYRIDOSTIGMINE BROMIDE TABLET [AMERICAN HEALTH PACKAGING] · version 11 · 2025-07-02
Showing the 12 most recent of 23 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.